Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
about
Radiogenomics and radiotherapy response modeling.Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival.The context of prostate cancer genomics in personalized medicine.A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer.Correction: Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.Molecular analyses of prostate tumors for diagnosis of malignancy on fine-needle aspiration biopsies.
P2860
Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Validation of Novel Biomarkers ...... inical and Functional Studies.
@ast
Validation of Novel Biomarkers ...... inical and Functional Studies.
@en
type
label
Validation of Novel Biomarkers ...... inical and Functional Studies.
@ast
Validation of Novel Biomarkers ...... inical and Functional Studies.
@en
prefLabel
Validation of Novel Biomarkers ...... inical and Functional Studies.
@ast
Validation of Novel Biomarkers ...... inical and Functional Studies.
@en
P2093
P2860
P1433
P1476
Validation of Novel Biomarkers ...... inical and Functional Studies.
@en
P2093
Anders Bjartell
Jesse Mattsson
Kim Pettersson
Matthias Nees
Natalia Tong Ochoa
Pekka Taimen
Peter J Boström
Riina-Minna Väänänen
Terhi Tallgrén
P2860
P304
P356
10.1371/JOURNAL.PONE.0155901
P407
P577
2016-05-19T00:00:00Z